Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects
This study has been completed.
First Received: July 22, 2008   Last Updated: February 5, 2009   History of Changes
Sponsored by: Wyeth
Information provided by: Wyeth
ClinicalTrials.gov Identifier: NCT00721474
  Purpose

A Study to determine if a high-fat meal has an effect on the pharmacokinetics of bosutinib.


Condition Intervention Phase
Healthy Subjects
Drug: Bosutinib
Phase I

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Crossover Assignment, Pharmacokinetics Study
Official Title: An Open-Label, Randomized, Single-Dose, 2-Period Crossover Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

Resource links provided by NLM:


Further study details as provided by Wyeth:

Primary Outcome Measures:
  • Pharmacokinetics (plasma concentrations) [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 24
Study Start Date: September 2008
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Bosutinib fasting
Drug: Bosutinib
Bosutinib fasting
2: Experimental
Bosutinib fed
Drug: Bosutinib
Bosutinib fed

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy men, age 18-50;
  • Healthy women of nonchildbearing potential, age 18-50.

Exclusion Criteria:

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00721474

Locations
United States, Washington
Tacoma, Washington, United States, 98418
Sponsors and Collaborators
Wyeth
Investigators
Study Director: Medical Monitor Wyeth
  More Information

No publications provided

Responsible Party: Wyeth ( Wyeth (Registry Contact: Clinical Trial Registry Specialist) )
Study ID Numbers: 3160A4-1110
Study First Received: July 22, 2008
Last Updated: February 5, 2009
ClinicalTrials.gov Identifier: NCT00721474     History of Changes
Health Authority: United States: Food and Drug Administration

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on September 09, 2009